StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Investment analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Friday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Stock Performance

Shares of MLSS stock opened at $0.93 on Friday. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.10. The company has a 50 day moving average price of $0.81 and a 200 day moving average price of $0.86. The stock has a market capitalization of $72.05 million, a P/E ratio of -13.21 and a beta of 1.10.

Insider Buying and Selling

In related news, Director Leonard Osser sold 107,984 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Over the last ninety days, insiders have sold 128,193 shares of company stock worth $116,234. Company insiders own 24.75% of the company’s stock.

Institutional Investors Weigh In On Milestone Scientific

Several institutional investors have recently added to or reduced their stakes in MLSS. Geode Capital Management LLC grew its holdings in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific during the 3rd quarter worth approximately $48,000. Finally, World Investment Advisors LLC purchased a new position in Milestone Scientific during the 3rd quarter worth approximately $91,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.